Skip to main content
SpringerLink
Log in

Palliation and Benign Conditions

  • Chapter
  • First Online:
Handbook of Evidence-Based Radiation Oncology

  • 2659 Accesses

Abstract

This chapter will cover brain metastases, bone metastases, spinal cord compression, liver metastases, airway obstruction, superior vena cava obstruction, and gynecologic bleeding.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  • Aiken KL, Hawkins MA. Stereotactic body radiotherapy for liver metastases. Clin Oncol. 2015;27:307–15.

    Article  Google Scholar 

  • Andrews DW, Scott CB, Sperduto PW, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet. 2004;363:1665–72.

    Article  Google Scholar 

  • Anker CJ, Grossmann KF, Atkins MB, et al. Avoiding severe toxicity from combined BRAF inhibitor and radiation treatment: consensus guidelines from the eastern cooperative oncology group (ECOG). Int J Radiat Oncol Biol Phys. 2016;95:632–46.

    Article  CAS  Google Scholar 

  • Aoyama H, Shirato H, Tago M, et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA. 2006;295(21):2483–91.

    Article  CAS  Google Scholar 

  • Atalar B, Modlin LA, Choi CYH, et al. Risk of leptomeningeal disease in patients treated with stereotactic radiosurgery targeting the postoperative resection cavity for brain metastases. Int J Radiat Oncol Biol Phys. 2013;87:713–8.

    Article  Google Scholar 

  • Berenson J, Pflugmacher R. Balloon kyphoplasty vs nonsurgical fracture management for treatment of painful vertebral body compression fractures in patients with cancer: a multicenter raondomized controlled trial. Lancet Oncol. 2011;12(3):225–35.

    Article  Google Scholar 

  • Blitzer PH. Reanalysis of the RTOG study of the palliation of symptomatic osseous metastasis. Cancer. 1985;55:1468–72.

    Article  CAS  Google Scholar 

  • Borgelt B, Gelber R, Kramer S, et al. The palliation of brain metastases: Final results fo the first two studies by the radiation therapy oncology group. Int J Radiat Oncol Biol Phys. 1980;6:1–9.

    Article  CAS  Google Scholar 

  • Borgelt B, Gelber R, Larson M, et al. Ultra-rapid high dose irradiation schedules for the Palliarion of brain metastases: Final results of the first two studies by the radiation therapy oncology group. Int J Radiat Oncol Biol Phys. 1981;7:1633–8.

    Article  CAS  Google Scholar 

  • Brennan C, Yang TJ, Hilden P, et al. A phase 2 trial of stereotactic radiosurgery boost after surgical resection for brain metastases. Int J Radiat Oncol Biol Phys. 2014;88:130–6.

    Article  Google Scholar 

  • Brown PD, Pugh S, Laack NN, et al. Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro-Oncol. 2013;15:1429–37.

    Article  CAS  Google Scholar 

  • Brown PD, Ballman KV, Cerhan J, et al. N107C/CEC.3: A phase III trial of postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease. ASTRO Annual Meeting, Boston, MA; Sept 2016a, LBA-1.

    Google Scholar 

  • Brown PD, Jaeckle K, Ballman KV, et al. Effect of radiosurgery alone vs radiosurgery with whole brain radiation therapy on cognitive function in patients with 1 to 3 brain metastases: a randomized clinical trial. JAMA. 2016b;316:401–9.

    Article  Google Scholar 

  • Chang EL, Wefel JS, Hess KR, et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol. 2009;10:1037–44.

    Article  Google Scholar 

  • Choi CYH, Chang SD, Gibbs IC, et al. Stereotactic radiosurgery of the postoperative resection cavity for brain metastases: prospective evaluation of target margin on tumor control. Int J Radiat Oncol Biol Phys. 2012;84:336–42.

    Article  Google Scholar 

  • Chow E, Zheng L, et al. Update on the systematic review of palliative radiotherapy trials for bone metastases. Clin Oncol. 2012;24(2):112–24.

    Article  CAS  Google Scholar 

  • Cox BW, et al. International spine radiosurgery consortium consensus guidelines for target volume definition in spinal stereotactic radiosurgery. IJROBP. 2012;83(5):e597–605.

    Google Scholar 

  • De Puysseleyr A, Van De Velde J, Speleers B, et al. Hair-sparing whole brain radiotherapy with volumetric arc therapy in patients treated for brain metastases: dosimetric and clinical results of a phase II trial. Radiat Oncol. 2014;9:170.

    Article  Google Scholar 

  • Ferrell BR, Temel JS et al. Integration of palliative care into standard oncology care: american society of clinical oncology clinical practice guideline update. Journal of Clinical Oncology 2017 35:1, 96–112

    Article  Google Scholar 

  • Flickinger JC, Kano H, Niranjan A. Dose selection in stereotactic radiosurgery. Prog Neurol Sur. 2013;27:49–57.

    Google Scholar 

  • Gaspar L, Scott C, Rotman M, et al. Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys. 1997;37:745–51.

    Article  CAS  Google Scholar 

  • Gaspar LE, Scott C, Murray K, Curran W. Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int J Radiat Oncol Biol Phys. 2000;47:1001–6.

    Article  CAS  Google Scholar 

  • Gerszten PC, Burton SA, Ozhasoglu C. Radiosurgery for spinal metastases: clinical experience in 500 cases from a single institution. Spine. 2007;32:193–9.

    Article  Google Scholar 

  • Goldberg SB, Gettinger SN, Mahajan A, Chiang AC, Herbst RS, Sznol M, et al. Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial. Lancet Oncol. 2016;17:976–83.

    Article  CAS  Google Scholar 

  • Gondi V, Pugh SL, Tome WA, et al. Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial. J Clin Oncol. 2014;32:3810–6.

    Article  Google Scholar 

  • Hartsell WF, Scott CB, Bruner DW, et al. Randomized trial of short-versus long-course radiotherapy for palliation of painful bone metastases. J Natl Cancer Inst. 2005;97:798–804.

    Article  Google Scholar 

  • Howell DD, James JL, Hartsell WF, et al. Randomized trial of short-course versus long-course radiotherapy for palliation of painful vertebral bone metastases: a retrospective analysis of RTOG 97-14. J Clin Oncol. 2009;27:7s. ASCO 2009, abstract

    Article  Google Scholar 

  • Iuchi T, Shingyoji M, Sakaida T, et al. Phase II trial of gefitinib alone without radiation therapy for Japanese patients with brain metastases from EGFR-mutant lung adenocarcinoma. Lung Cancer. 2013;82:282–7.

    Article  CAS  Google Scholar 

  • Jabbari S, Gerszten P, Ruschin M, et al. Stereotactic body radiotherapy for spinal metastases: practical guidelines, outcomes, and risks. Cancer J. 2016;22(4):280–9.

    Article  Google Scholar 

  • Jensen CA, Chan MD, McCoy TP, et al. Cavity-directed radiosurgery as adjuvant therapy after resection of a brain metastasis. J Neurosurg. 2011;114:1585–91.

    Article  Google Scholar 

  • Johung KL, Yeh N, Desai NB, et al. Extended survival and prognostic factors for patients with ALK-rearranged non-small-cell lung cancer and brain metastasis. J Clin Oncol. 2016;34:123–9.

    Article  CAS  Google Scholar 

  • Kayama T, Sato S, Sakurata K, et al. JCOG0504: a phase III randomized trial of surgery with whole brain radiation therapy versus surgery with salvage stereotactic radiosurgery in paitnets with 1 to 4 brain metastases. Abstract only. J Clin Oncol. 2016;34:Suppl abst 2003.

    Google Scholar 

  • Knisely JPS, Yu JB, Flanigan J, et al. Radiosurgery for melanoma brain metastases in the ipilimumab era and the possibility of longer survival. J Neurosurg. 2012;117:227–33.

    Article  Google Scholar 

  • Kocher M, Soffietti R, Abacioglu U, et al. Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study. J Clin Oncol. 2011;29:134–41.

    Article  Google Scholar 

  • Kondziolka D, Patel A, Lunsford LD, et al. Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys. 1999;45:427–34.

    Article  CAS  Google Scholar 

  • Kroeze SG, Fritz C, Hoyer M, et al. Toxicity of concurrent stereotactic radiotherapy and targeted therapy or immunotherapy: a systematic review. Cancer Treat Rev. 2017;53:25–37.

    Article  Google Scholar 

  • Ling DC, Vargo JA, Wegner RE, et al. Postoperative stereotactic radiosurgery to the resection cavity for large brain metastases. Neurosurgery. 2015;76:150–7.

    Article  Google Scholar 

  • Lo SS, Ryu S, Chang EL, et al. ACR appropriateness criteria: metastatic epidural spinal cord compression and recurrent spinal metastases. J Palliative Med. 2015;8:573–84.

    Google Scholar 

  • Logie N, Jimenez RB, Pulenzas RB, et al. Recursive partitioning analysis to predict survival for patients receiving cranial re-irradiation for brain metastases. IJROBP. 2015;93(3 supp):S62–3.

    Google Scholar 

  • Lutz SJ, Balboni T, Jones J, Lo S, Petit J, et al. Palliative radiation therapy for bone metastases: update of an ASTRO evidence-based guideline. Prac Radiat Oncol. 2017;7(1):4–12.

    Article  Google Scholar 

  • Magnuson WJ, Lester-Coll NH, Wu AJ, et al. Management of Brain Metastases in tyrosine kinase inhibitor-Naïve epidermal growth factor receptor-mutant non-small-cell lung cancer: a retrospective multi-institutional analysis. J Clin Oncol. 2017;35(10):1070–7.

    Article  CAS  Google Scholar 

  • Mahajan A, Ahmed S, McAleer MF, et al. Postoperative stereotactic radiosurgery versus observation for completely resected brain metastases: results of a prostpective randomized study. Abstract only. IJROBP. 2016;96-2:s2.

    Google Scholar 

  • Mak KS, Gainor JF, Niemierko A, Oh KS, Willers H, Choi NC, et al. Significance of targeted therapy and genetic alterations in EGFR, ALK, or KRAS on survival in patients with non-small cell lung cancer treated with radiotherapy for brain metastases. Neuro-Oncol. 2015;17:296–302.

    Article  CAS  Google Scholar 

  • Margolin K, Ernstoff MS, Hamid O, et al. Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial. Lancet Oncol. 2012;13:459–65.

    Article  CAS  Google Scholar 

  • McCarter MD, Fong Y. Metastatic liver Tumors. Semin Surgl Oncol. 2000;19:177–88.

    Article  CAS  Google Scholar 

  • Minniti G, Esposito V, Clarke E, et al. Multidose stereotactic radiosurgery (9 Gy × 3) of the postoperative resection cavity for treatment of large brain metastases. Int J Radiat Oncol Biol Phys. 2013;86:623–9.

    Article  Google Scholar 

  • Minniti G, D’Angelillo RM, Scaringi C, et al. Fractionated stereotactic radiosurgery for patients with brain metastases. J Neuro-Oncol. 2014;117(2):295–301.

    Article  CAS  Google Scholar 

  • Mirels H. Metastatic disease in long bones. A proposed scoring system for diagnosing impending pathologic fractures. Clin Orthop Relat Res. 1989;249:256–64.

    Google Scholar 

  • Mulvenna P, Nankivell M, Barton R, et al. Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial. Lancet. 2016;388:2004–14.

    Article  CAS  Google Scholar 

  • Navarria P, Pessina F, Cozzi L, et al. Hypo-fractionated stereotactic radiotherapy alone using volumetric modulated arc therapy for patients with single, large brain metastases unsuitable for surgical resection. Radiat Oncol. 2016;11:76.

    Article  Google Scholar 

  • Nousianinen M. Surgical management of bone metastases. In: Bone metastases, a translational and clinical approach, vol. 12. Dordrecht: Springer; 2009. p. 263–86.

    Chapter  Google Scholar 

  • Ou S-HI, Jänne PA, Bartlett CH, et al. Clinical benefit of continuing ALK inhibition with crizotinib beyond initial disease progression in patients with advanced ALK-positive NSCLC. Ann Oncol. 2014;25:415–22.

    Article  Google Scholar 

  • Pan C, Kavanagh B, et al. Radiation associated liver injury. IJROBP. 2010;76(3):S94–S100.

    Google Scholar 

  • Patchell RA, Tibbs PA, Walsh JW, et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med. 1990;322:494–500.

    Article  CAS  Google Scholar 

  • Patchell RA, Tibbs PA, Regine WF, et al. Postoperative radiotherapy in the treatment of single metastases to the brain. JAMA. 1998;280:1485–9.

    Article  CAS  Google Scholar 

  • Patchell RA, Tibbs PA, Regine WF, et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet. 2005;366:643–8.

    Article  Google Scholar 

  • Park SJ, Kim HT, Lee DH, et al. Efficacy of epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in non-small cell lung cancer patients harboring either exon 19 or 21 mutation. Lung Cancer. 2012;77:556–60.

    Article  CAS  Google Scholar 

  • Porter AT, McEwan AJ, Powe JE, et al. Results of a randomized phase III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the Management of Endocrine Resistant Metastatic Prostate Cancer. Int J Radiat Oncol Biol Phys. 1993;25:805–13.

    Article  CAS  Google Scholar 

  • Rades D, Rudat V, Veninga T, et al. Prognostic factors for functional outcome and survival after Reirradiation for in-field recurrences of metastatic spinal cord compression. Cancer. 2008;113:1090–6.

    Article  Google Scholar 

  • Rades D, Lange M, Veniga T, et al. Final results of a prospective study comparing the local control of short course and long course radiotherapy for metastatic spinal cord compression. IJROBP. 2011a;79(2):524–30.

    Google Scholar 

  • Rades D, Stalpers LJA, Hulshof MC, et al. Comparison of 1 x 8 Gy and 10 x 3 Gy for functional outcome in patients with metastatic spinal cord compression. Int J Radiat Oncol Biol Phys. 2005;62:514–8.

    Article  Google Scholar 

  • Rades D, Panzner A, Rudat V, et al. Dose escalation of radiotherapy for metastatic spinal cord compression in patients with relativel favorable survival prognosis. Strahlenther Onkol. 2011b;187(11):729–35.

    Article  Google Scholar 

  • Rades D, Segedin B, Conde-Moreno A, et al. Radiotherapy with 4 Gy x 5 versus 3 Gy x 10 for metastatic epidural spinal cord compression: Final results of the SCORE-2 trial (ARO2009/01). J Clin Oncol. 2016;34(6):597–602.

    Article  CAS  Google Scholar 

  • Redmond KJ, Robertson S, Lo S, Soltys S, et al. Consensus contouring guidelines for postoperative stereotactic body radiation therapy for Metastastic solid tumor malignancies to the spine. Int J Radiat Oncol Biol Phys. 2017;97(1):64–74.

    Article  Google Scholar 

  • Reveiz L, et al. Palliative endobroncial brachytherapy for non-small cell lung cancer. Cochrane Review. 2012;12:CD004284.

    PubMed  Google Scholar 

  • Rodrigues G et al. Palliative thoracic radiotherapy in lung cancer: an american society for radiation oncology evidence-based clinical practice guideline. Practical Radiation Oncology 1.2 (2011): 60–71.

    Article  Google Scholar 

  • Rusthoven CG, Doebele RC. Management of Brain Metastases in ALK-positive non-small-cell lung cancer. J Clin Oncol. 2016;34:2814–9.

    Article  Google Scholar 

  • Rusthoven KE, Kavanagh BD, Cardenes H, et al. Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol. 2009;27(10):1572–8.

    Article  Google Scholar 

  • Sahgal A, Ames C, Chou D, et al. Stereotactic body radiotherapy is effective salvage therapy for patients with prior radiation of spinal metastases. Int J Radiat Oncol Biol Phys. 2009;74(3):723–31.

    Article  Google Scholar 

  • Scharp M, Hauswald H, Bischof M, et al. Re-irradiation in the treatment of patients with cerebral metastases of solid tumors: retrospective analysis. Radiat Oncol. 2014;9:4.

    Article  Google Scholar 

  • Sciuto R, Festa A, Rea S, et al. Effects of low-dose cisplatin on 89Sr therapy for painful bone metastases from prostate cancer: a randomized clinical trial. J Nucl Med. 2002;43:79–86.

    CAS  PubMed  Google Scholar 

  • Shaw E, Scott C, Souhami L, et al. Single dose Radiosurgical treatment of recurrent previously irradiated primary brain Tumors and brain metastases: Final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys. 2000;47:291–8.

    Article  CAS  Google Scholar 

  • Sirven JI, Wingerchuk DM, Drazkowski JF, et al. Seizure prophylaxis in patients with brain tumors: a meta-analysis. Mayo Clin Proc. 2004;79:1489–94.

    Article  Google Scholar 

  • Sneed PK, Lamborn KR, Forstner JM, et al. Radiosurgery for brain metastases: is whole brain radiotherapy necessary? Int J Radiat Oncol Biol Phys. 1999;43:549–58.

    Article  CAS  Google Scholar 

  • Sneed PK, Suh JH, Goetsch SJ, et al. A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases. Int J Radiat Oncol Biol Phys. 2002;53:519–26.

    Article  Google Scholar 

  • Sneed PK, Mendez J, Vemer-van den Hoek JGM, Seymour ZA, Ma L, Molinaro AM, et al. Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors. J Neurosurg. 2015;123:373–86.

    Article  CAS  Google Scholar 

  • Soltys SG, Adler JR, Lipani JD, et al. Stereotactic radiosurgery of the postoperative resection cavity for brain metastases. Int J Radiat Oncol Biol Phys. 2008;70:187–93.

    Article  Google Scholar 

  • Son CH, Jimenez R, Niemierko A, et al. Outcomes after whole brain reirradiation in patients with brain metastases. Int J Radiat Oncol Biol Phys. 2012;82:e167–72.

    Article  Google Scholar 

  • Spanos WT et al. Late effect of multiple daily fraction palliation schedule for advanced pelvic malignancies (RTOG 8502), IJROBP 29:5, 1994, P 961–967.

    Article  Google Scholar 

  • Sperduto PW, Berkey B, Gaspar LE, et al. A new prognostic index and Comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database. Int J Radiat Oncol Biol Phys. 2008;70:510–4.

    Article  Google Scholar 

  • Sperduto PW, Chao ST, Sneed PK, et al. Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. Int J Radiat Oncol Biol Phys. 2010;77:655–61.

    Article  Google Scholar 

  • Sperduto PW, Kased N, Roberge D, et al. Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases. J Clin Oncol. 2012;30:419–25.

    Article  Google Scholar 

  • Stopeck AT. Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double blind study. JCO. 2010;28(35):5132–9.

    Article  CAS  Google Scholar 

  • Thibault I, Whyne C, Zhou S, Campbell M, et al. Volume of lytic vertebral body metastatic disease quantified using computer tomography-based image segmentation predicts fracture risk after spine stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. 2017;97(1):75–81.

    Article  Google Scholar 

  • Tremont-Lukats IW, Ratilal BO, Armstrong T, et al. Antiepileptic drugs for preventing seizures in people with brain tumors. Cochrane Database Syst Rev 2008;(16):CD004424.

    Google Scholar 

  • Tsao MN, Lloyd N, Wong RKS, et al. Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases. Cochrane Database Syst Rev 2012a;(18):CD003869.

    Google Scholar 

  • Tsao MN, Rades D, Wirth A, et al. Radiotherapeutic and surgical management for newly diagnosed brain metastases: an amarican society for radiation oncology evidence based guideline. Prac Radiat Oncol. 2012b;2(3):210–25.

    Article  Google Scholar 

  • Van der Linden YM, Dijkstra PD, Kroon HM, et al. Comparative analysis of risk factors for pathological fracture with femoral metastases. J Bone Joint Surg Br. 2004;86:566–73.

    Article  Google Scholar 

  • Wang TJC, Saad S, Qureshi YH, et al. Does lung cancer mutation status and targeted therapy predict for outcomes and local control in the setting of brain metastases treated with radiation? Neuro-Oncol. 2015;17:1022–8.

    Article  Google Scholar 

  • Weber JS, Amin A, Minor D, et al. Safety and clinical activity of ipilimumab in melanoma patients with brain metastases: retrospective analysis of data from a phase 2 trial. Melanoma Res. 2011;21:530–4.

    Article  CAS  Google Scholar 

  • Weickhardt AJ, Scheier B, Burke JM, et al. Local ablative therapy of oligoprogressive disease prolongs disease control by tyrosine kinase inhibitors in oncogene-addicted non-small-cell lung cancer. J Thorac Oncol. 2012;7:1807–14.

    Article  CAS  Google Scholar 

  • Wilson L, et al. Superior vena cava syndrome with malignant causes. NEJM. 2007;356:1862–9.

    Article  CAS  Google Scholar 

  • Yamamoto M, Serizawa T, Shuto T, et al. Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study. Lancet Oncol. 2014;15:387–95.

    Article  Google Scholar 

Download references

Acknowledgment

We thank Stuart Y. Tsuji MD, PhD, and William M. Wara MD for their work on the prior edition of this chapter.

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA

    Lauren Boreta & Yao Yu

  2. Radiation Oncology, University of California San Francisco, San Francisco, CA, USA

    Steve E. Braunstein

Authors
  1. Lauren Boreta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yao Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Steve E. Braunstein
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lauren Boreta .

Editor information

Editors and Affiliations

  1. The Oregon Clinic, Providence St. Vincent Medical Center, Portland, OR, USA

    Eric K. Hansen

  2. Department of Radiation Oncology, University of California, San Franc, SAN FRANCISCO, CA, USA

    Mack Roach III

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Boreta, L., Yu, Y., Braunstein, S.E. (2018). Palliation and Benign Conditions. In: Hansen, E., Roach III, M. (eds) Handbook of Evidence-Based Radiation Oncology. Springer, Cham. https://doi.org/10.1007/978-3-319-62642-0_42

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-62642-0_42

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-62641-3

  • Online ISBN: 978-3-319-62642-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation